ZA201100468B - The treatment of helminthic infections - Google Patents
The treatment of helminthic infectionsInfo
- Publication number
- ZA201100468B ZA201100468B ZA2011/00468A ZA201100468A ZA201100468B ZA 201100468 B ZA201100468 B ZA 201100468B ZA 2011/00468 A ZA2011/00468 A ZA 2011/00468A ZA 201100468 A ZA201100468 A ZA 201100468A ZA 201100468 B ZA201100468 B ZA 201100468B
- Authority
- ZA
- South Africa
- Prior art keywords
- treatment
- helminthic infections
- helminthic
- infections
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
- A61P33/12—Schistosomicides
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ZA200802695 | 2008-03-26 | ||
PCT/IB2009/051269 WO2009118706A2 (en) | 2008-03-26 | 2009-03-26 | The treatment of helminthic infections |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA201100468B true ZA201100468B (en) | 2011-10-26 |
Family
ID=41114398
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA2011/00468A ZA201100468B (en) | 2008-03-26 | 2011-01-18 | The treatment of helminthic infections |
Country Status (2)
Country | Link |
---|---|
WO (1) | WO2009118706A2 (en) |
ZA (1) | ZA201100468B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012051633A1 (en) * | 2010-10-15 | 2012-04-19 | Tri Laz Meds Sa (Pty) Ltd | The treatment of helminthic infections. |
WO2013093790A1 (en) * | 2011-12-22 | 2013-06-27 | Shoket Latief | A composition for reducing an hiv viral load comprising praziquantel, niclosamide and albendazole |
-
2009
- 2009-03-26 WO PCT/IB2009/051269 patent/WO2009118706A2/en unknown
-
2011
- 2011-01-18 ZA ZA2011/00468A patent/ZA201100468B/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2009118706A2 (en) | 2009-10-01 |
WO2009118706A9 (en) | 2010-01-14 |
WO2009118706A3 (en) | 2009-12-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL213619A0 (en) | Treatment | |
GB0802116D0 (en) | Treatment | |
GB0818074D0 (en) | Treatment of biofilms | |
EP2273989A4 (en) | Combination therapy for the treatment of bacterial infections | |
ZA201005798B (en) | Treatment of microbial infections | |
GB0822011D0 (en) | Treatment | |
GB0803026D0 (en) | External surface treatment system | |
HK1161886A1 (en) | Novel antibacterial agents for the treatment of gram positive infections | |
EP2249789A4 (en) | Compositions and methods for the treatment of xerostomia | |
GB0811992D0 (en) | Treatment | |
ZA201000225B (en) | Treatment of depression | |
EP2271328A4 (en) | Antiseptic compositions for the treatment of infections | |
GB0723100D0 (en) | Treatment of HFnEF | |
EP2164494A4 (en) | Methods of treatment | |
ZA201100468B (en) | The treatment of helminthic infections | |
IL202506A0 (en) | Neramexane for the treatment of nystagmus | |
GB0820972D0 (en) | Treatment | |
HK1139050A1 (en) | Medicament for the treatment of pneumonia | |
GB0805912D0 (en) | Treatment | |
EP2328577A4 (en) | The treatment of hearing loss | |
GB0602857D0 (en) | The treatment of sialorrhoea | |
GB0809319D0 (en) | The treatment of puritus | |
GB2465211B (en) | Treatment Solution | |
ZA200907826B (en) | Neramexane for the treatment of nystagmus | |
GB0817437D0 (en) | Compounds for the treatment of flaviviral infections |